Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2005
12/08/2005US20050271614 Type V telopeptide-containing collagen protein combined with a drug that may be an antibiotic, an anti-fungal, an anti-dandruff agent, an anti-itch agent, a sunburn treatment agent, an acne treatment agent or an wrinkle-minimizing agent.
12/08/2005US20050271604 Matrix protein compositions for wound healing
12/08/2005US20050271603 Compositions comprising lactoferrin
12/08/2005US20050271588 Liposome targeting of matrix metalloproteinase inhibitors
12/08/2005US20050271587 Exposing the cancer cell to a peptide has antiestrotrophic activity and is eight to twenty amino acids long; use of tamoxifen therapy in combination with the peptide therapy
12/08/2005DE60017281T2 Nomegestrolacetat und östrogen enthaltende Hormonzusammensetzung und ihre Verwendung Nomegestrol acetate and estrogen hormone-containing composition and its use
12/08/2005DE102004025988A1 Verwendung von Vanadylverbindungen zur Behandlung von Tumorerkrankungen Use of vanadyl compounds for the treatment of tumor diseases
12/08/2005DE102004022928A1 Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung Powder containing Oligosacharidgemische novel and processes for their preparation
12/08/2005CA2848881A1 Treatment of depressive disorders
12/08/2005CA2777821A1 Mhc molecule-binding tumor-associated peptides
12/08/2005CA2604243A1 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
12/08/2005CA2586222A1 Enzymes for pharmaceutical use
12/08/2005CA2568714A1 A biomolecule-containing formulation of increased stability
12/08/2005CA2568409A1 A chronic joint inflammation-modulating composition made of collagen-polyvinylpyrrolidone
12/08/2005CA2568363A1 Natriuretic compounds, conjugates, and uses thereof
12/08/2005CA2568254A1 Tumor-associated peptides that bind to mhc-molecules
12/08/2005CA2568201A1 Identification of ergothioneine transporter and therapeutic uses thereof
12/08/2005CA2567961A1 Superloaded liposomes for drug delivery
12/08/2005CA2567810A1 Cerberus/coco derivatives and uses thereof
12/08/2005CA2567405A1 Use of morphogenic proteins for treating cartilage defects
12/08/2005CA2567099A1 Induction of innate immunity by vitamin d3 and its analogs
12/08/2005CA2567056A1 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
12/08/2005CA2566861A1 Methods and reagents for the treatment of immunoinflammatory disorders
12/08/2005CA2566481A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities
12/08/2005CA2566478A1 Alpha-msh-antagonist didpeptide conjugates
12/08/2005CA2565886A1 Treatment of inflammatory airway disease
12/08/2005CA2565805A1 Msh-agonist tripeptide conjugates
12/08/2005CA2565794A1 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment
12/08/2005CA2565545A1 Treatment of ocular diseases and disorders using lantibiotic compositions
12/08/2005CA2565330A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
12/08/2005CA2565259A1 Soluble lfa-3 polypeptide for treating viral disorders
12/08/2005CA2564868A1 Methods for treating or preventing restenosis and other vascular proliferative disorders
12/08/2005CA2563999A1 Keratin-binding polypeptides
12/08/2005CA2563926A1 Transgenic models of alzheimer's disease and uses thereof in the treatment of a variety of neurodegenerative diseases
12/08/2005CA2562683A1 Adamts-8 proteins and uses thereof
12/07/2005EP1602931A1 SR-A antagonists
12/07/2005EP1602930A2 Use of compounds that bind to GPR49 for diagnosis and treatment of cancer
12/07/2005EP1602925A2 Methods for treatment of aneurysmal tissue
12/07/2005EP1602726A2 Human tachykinin-related splice variants and compositions thereof
12/07/2005EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/07/2005EP1602667A1 Aqueous formulation comprising TFPI and solubilising agents
12/07/2005EP1602666A1 Novel protein and its dna
12/07/2005EP1602665A1 Physiologically active peptides and drugs containing the same
12/07/2005EP1602664A1 HCV E1 comprising specific disulfide bridges
12/07/2005EP1602380A1 Preventive/remedy for diseases in upper digestive tract
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602378A1 Method for administering a cytokine to the central nervous system and the lymphatic system
12/07/2005EP1602284A1 Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
12/07/2005EP1601965A2 Animal model simulating neurologic disease
12/07/2005EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
12/07/2005EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
12/07/2005EP1601772A1 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
12/07/2005EP1601769A1 Papillosin antimicrobial peptide, a gene for coding said peptide, a vector, a transformed organism and a compound containing said organism
12/07/2005EP1601768A2 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide
12/07/2005EP1601756A2 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
12/07/2005EP1601696A1 Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasia
12/07/2005EP1601694A2 Uses of il-23 agonists and antagonists; related reagents
12/07/2005EP1601692A2 Enzymes involved in apoptosis
12/07/2005EP1601691A2 Shrew paralytic peptide for use in neuromuscular therapy
12/07/2005EP1601688A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae
12/07/2005EP1601685A1 Hepatitis c inhibiting compounds
12/07/2005EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
12/07/2005EP1601681A2 Oligonucleotide mimetics
12/07/2005EP1601377A2 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
12/07/2005EP1601373A2 Intracellular delivery of small molecules proteins and nucleic acids
12/07/2005EP1601372A2 Clk-peptide and slk-peptide
12/07/2005EP1601371A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
12/07/2005EP1601368A2 Methods and compositions for treatment of viral diseases
12/07/2005EP1601364A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds
12/07/2005EP1601343A1 New process for the production of implants
12/07/2005EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
12/07/2005EP1601331A2 Il-2 transmembrane constructs
12/07/2005EP1601328A2 Polyvalent immunogen
12/07/2005EP1601327A2 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis
12/07/2005EP1601324A2 Hemostatic compositions and methods
12/07/2005EP1578983A3 Methods for regulating co-stimulatory molecule expression with reactive oxygen
12/07/2005EP1513874A4 Compositions and methods of use for a bombesin peptide
12/07/2005EP1463408A4 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
12/07/2005EP1439840B1 Monobactam antibacterial compounds and methods of use thereof
12/07/2005EP1423409A4 Gastrokines and derived peptides including inhibitors
12/07/2005EP1337228B1 Compositions for removing human cerumen
12/07/2005EP1290451B1 Diagnosis of alzheimer's disease using ldl receptor protein-1
12/07/2005EP1266006B1 Production of recombinant muteins of blood clotting factor viii in human cell lines
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1220887B1 Protein-containing granules and granule formulations
12/07/2005EP1178812B1 Methods of making conditioned cell culture medium compositions
12/07/2005EP1165118B1 Treatment of multiple sclerosis with a combination of interferon and growth hormone
12/07/2005EP1156809B1 Mucin containing ophthalmic preparations
12/07/2005EP1117426B1 Akt compositions for enhancing survival of cardiomyocytes
12/07/2005EP1109579B1 Use of tgf-beta inhibitors for treating cerebral disorders
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP1030567B9 System for dialysis and shock treatment
12/07/2005EP1019514B1 A keratinocyte derived protease
12/07/2005EP0998568B1 Mutant having uracil phosphoribosyl transferase activity
12/07/2005EP0996717B1 Immunoprotective influenza antigen and its use in vaccination
12/07/2005EP0922105B1 Infectious papillomavirus pseudoviral particles
12/07/2005EP0831812B1 Methods and compositions for stimulating neurite growth
12/07/2005EP0794794B1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
12/07/2005EP0738328B1 Composition containing nucleic acids, preparation and uses
12/07/2005EP0716701B1 Agent comprising serine-threonine kinase for the diagnostic and therapy of tumors
1 ... 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 ... 3163